Catheter Precision

Catheter Precision EPS

The Earnings per Share (EPS) of Catheter Precision (VTAK) as of Oct 21, 2026 is -0.02 USD. In the previous year, Earnings per Share (EPS) was -2.08 USD — a change of -99.24% (higher).

EPS

-0.02USD

YoY

-99.24%

Last updated:

Earnings per Share (EPS) of Catheter Precision is 2025 -0.02 USD. Earnings per Share (EPS) of Catheter Precision was 2024 -2.08 USD. It decreases by -99.24% higher compared to the previous year.

The Catheter Precision EPS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EPS
Date
EPS
Jan 1, 2019
-5,273.80 USD
Jan 1, 2020
-622.54 USD
Jan 1, 2021
-185.98 USD
Jan 1, 2022
-2,356.58 USD
Jan 1, 2023
-10.04 USD
Jan 1, 2024
-2.08 USD
Jan 1, 2025
-0.02 USD
Jan 1, 2026 (e)
-3.20 USD
The Catheter Precision EPS history
YEAREPSYoY
est-3.20USD+20,024.39%
-0.02USD-99.24%
-2.08USD-79.30%
-10.04USD-99.57%
-2,356.58USD+1,167.12%
-185.98USD-70.13%
-622.54USD-88.20%
-5,273.80USD+74.47%
-3,022.75USD+65.05%
-1,831.44USD+120.62 M%
-0.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Catheter Precision Stock analysis

What does Catheter Precision do? Ra Medical Systems, Inc. generates revenue through the sale of its electrophysiology products Amigo, VIVO, and LockeT to hospitals, physicians, and healthcare providers. The company's Amigo remote catheter system, featuring an open architecture design, allows for versatile use across multiple catheter procedures. VIVO, a non-invasive 3D imaging system, helps physicians identify arrhythmia origins pre-procedure, improving workflow efficiency. LockeT, a suture retention device, supports surgical procedures. These products target cardiac arrhythmia treatment, serving medical institutions and healthcare professionals seeking advanced solutions for patient care. The firm collaborates with physicians to develop and advance its electrophysiology technologies, focusing on improving cardiac arrhythmia procedures. Its product portfolio addresses the need for streamlined workflows and reduced procedure times in electrophysiology settings. Hospitals and physicians purchase these solutions to enhance patient outcomes and operational efficiency in treating vascular immune-mediated inflammatory diseases. The company's commercialization strategy centers on delivering innovative technologies that meet evolving clinical demands in cardiology. Ra Medical Systems, Inc. is engaged in providing new solutions to the market for cardiac arrhythmia treatment, emphasizing technology development for electrophysiology procedures. Its products are designed to improve patient lives through advanced catheter-based systems and imaging solutions. The company's focus on physician collaboration ensures that its offerings align with clinical needs, driving adoption among healthcare providers specializing in cardiac care. Catheter Precision is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Catheter Precision stock

Earnings per Share (EPS) of Catheter Precision is -0.02 USD in 2025.

Earnings per Share (EPS) of Catheter Precision changed from -2.08 USD to -0.02 USD, representing a -99.24% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Earnings per Share (EPS) Catheter Precision since 2006 – with annual values, charts, and detailed analysis.

Earnings per Share measures the portion of a company's profit allocated to each outstanding share. It is a key metric for assessing a company's profitability on a per-share basis.

EPS = Net Income / Shares Outstanding

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Catheter Precision

All Key Metrics — Catheter Precision